Daylife Select
A point & click tool to create dynamic content portals. Learn More »
RNRL's submissions on the MoU : If generics are the gateway of growth for global pharmaceutical giants such as AstraZeneca, Pfizer, Sanofi-Aventis, Novartis, Merck and GlaxoSmithKline, there is a clear and renewed thrust on the $17 billion Indian... Full Article at Expressindia.com